Research and Markets: Pioneering Pharma ...

Physicians treating rare blood disorders are gaining more drug treatments to choose from, which allow patients to avoid demanding surgeries and chemotherapy, and fill the pockets of pharmaceutical companies who can charge top dollar in these untapped markets.

http://www.financialmirror.com/newsml_story.php?id=9438